Marcaine With Epinephrine Injection, Solution
Product Images NDC 0409-4208

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Marcaine With Epinephrine (NDC 0409-4208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Marcaine 01)

Chemical structure diagram of Bupivacaine Hydrochloride. The diagram shows the molecular arrangement including the piperidine ring, aromatic ring with methyl groups, and the hydrochloride and water components.*

FDA Label Image

Chemical Structure (Marcaine 02)

Chemical structure diagram displaying the molecular composition of bupivacaine hydrochloride combined with epinephrine, shown as two separate molecular structures side by side.*

FDA Label Image

Logo (Marcaine 03)

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Label)

Marcaine with Epinephrine 0.25% (bupivacaine hydrochloride and epinephrine injection) label for a 10 mL single-dose vial. The label indicates the solution strength as 25 mg/10 mL (2.5 mg/mL) bupivacaine hydrochloride with epinephrine 1:200,000 (0.0091 mg/mL). It is preservative-free for infiltration, nerve block, caudal, and epidural anesthesia but not for intrathecal use. Contains warnings about epinephrine and sulfites and storage instructions. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (25 mg/10 mL Vial Carton)

Packaging label for Marcaine with Epinephrine injection, solution 0.25% (2.5 mg/mL) strength. The label states the active ingredients bupivacaine hydrochloride and epinephrine, USP for infiltration, nerve block, caudal and epidural anesthesia but not for intrathecal anesthesia. The package contains 10 single-dose vials of 10 mL each, preservative-free. The label includes warnings about sulfites and instructions to avoid autoclaving. The product is distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Label)

Label for Marcaine with Epinephrine 0.25% injection solution, 125 mg per 50 mL (2.5 mg/mL), in a 50 mL multiple-dose vial. Contains bupivacaine hydrochloride and epinephrine as bitartrate at a concentration of 1:200,000. Intended for infiltration and nerve block anesthesia, not for caudal, epidural, or intrathecal use. Label warns of containing epinephrine and sulfites. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (125 mg/50 mL Vial Carton)

Label for Marcaine 0.25% (125 mg/50 mL or 2.5 mg/mL) injection, solution in a 50 mL multiple-dose vial. Contains bupivacaine hydrochloride and epinephrine 1:200,000 (as bitartrate). Indicated for infiltration and nerve block use. Distributed by Hospira, Inc. with detailed storage and handling instructions included on the label.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Label)

Label of Marcaine with Epinephrine injection, a preservative-free solution containing bupivacaine hydrochloride and epinephrine. The concentration is 0.25% (75 mg per 30 mL or 2.5 mg/mL) with epinephrine at a 1:200,000 ratio. The label specifies use for infiltration, nerve block, caudal, and epidural anesthesia, not for intrathecal anesthesia. Distributed by Hospira, Inc., the label includes warnings about sulfites and contraindications for intrathecal use.*

FDA Label Image

Principal Display Panel (75 mg/30 mL Vial Carton)

Packaging label for Marcaine 0.25% (75 mg/30 mL, 2.5 mg/mL) injection solution with epinephrine 1:200,000 (as bitartrate). The label indicates 30 mL single-dose vials, preservative-free, for infiltration, nerve block, caudal, and epidural anesthesia, not for intrathecal anesthesia. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Label)

Label for Marcaine with Epinephrine 0.5% (50 mg/10 mL) injection solution by Hospira, Inc. It is a 10 mL single-dose vial of preservative-free bupivacaine hydrochloride and epinephrine injection for nerve block, caudal, and epidural anesthesia. The label includes warnings about containing sulfites, instructions not to autoclave, and storage conditions.*

FDA Label Image

Principal Display Panel (50 mg/10 mL Vial Carton)

Packaging label for Marcaine 0.5% (50 mg/10 mL, 5 mg/mL) injection solution with epinephrine 1:200,000 (as bitartrate). This preservative-free product contains bupivacaine hydrochloride and epinephrine for nerve block, caudal, and epidural anesthesia. The label indicates 10 single-dose 10 mL vials, manufactured and distributed by Hospira, Inc., and notes it is not for intrathecal anesthesia. Contains warnings about sulfites and specifies the product is for prescription use only.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Label)

Label for Marcaine with Epinephrine 0.5% injection, a solution containing 150 mg/30 mL (5 mg/mL) of bupivacaine hydrochloride with epinephrine 1:200,000 as bitartrate. It is preservative-free, supplied in a 30 mL single dose vial, and indicated for nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia. The product is manufactured by Hospira, Inc. and includes warnings for sulfites and epinephrine.*

FDA Label Image

Principal Display Panel (150 mg/30 mL Vial Carton)

Packaging label for Marcaine with Epinephrine 0.5% injection, solution with 150 mg/30 mL (5 mg/mL) strength. The label notes it contains epinephrine 1:200,000 (as bitartrate) and is preservative-free. It is indicated for nerve block, caudal, and epidural anesthesia but not for intrathecal anesthesia. Distributed by Hospira, Inc., the package contains 10 single-dose 30 mL vials and includes warnings for sulfites.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Label)

Label for Marcaine with Epinephrine 0.5% (5 mg/mL) injection solution in a 250 mg/50 mL vial, containing bupivacaine hydrochloride and epinephrine for nerve block by Hospira, Inc. The label highlights that it is not for caudal, epidural, or intrathecal anesthesia and includes warnings about epinephrine and sulfites content. Storage and composition details are also noted.*

FDA Label Image

Principal Display Panel (250 mg/50 mL Vial Carton)

Packaging label for Marcaine with Epinephrine 0.5% injection solution, containing 250 mg/50 mL (5 mg/mL) in a 50 mL multiple-dose vial. The label notes the active ingredients bupivacaine hydrochloride and epinephrine (as bitartrate) at 1:200,000 concentration. Produced by Hospira, Inc., the label includes storage instructions, usage warnings, and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.